1. Home
  2. LITB vs PYPD Comparison

LITB vs PYPD Comparison

Compare LITB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$2.48

Market Cap

43.0M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.39

Market Cap

73.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
PYPD
Founded
2007
2008
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.0M
73.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LITB
PYPD
Price
$2.48
$4.39
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
25.8K
76.9K
Earning Date
11-12-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$219,105,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$2.30
52 Week High
$4.17
$4.63

Technical Indicators

Market Signals
Indicator
LITB
PYPD
Relative Strength Index (RSI) 61.67 69.88
Support Level $2.20 $4.10
Resistance Level $2.89 $4.63
Average True Range (ATR) 0.37 0.17
MACD 0.07 0.03
Stochastic Oscillator 70.83 59.46

Price Performance

Historical Comparison
LITB
PYPD

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: